Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies

Inhibition of WEE1 Kinase & Cell Cycle Checkpoint Activation Sensitizes Head and Neck Cancers to NK Cell Therapies @theNCI @NIH https://t.co/txKX7aapnF

RT @sitcancer: #JITC Research: Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural k…

RT @sitcancer: #JITC Research: Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural k…

RT @Becker_MichaelD: AstraZeneca's adavosertib (AZD1775) is the inhibitor of WEE1 kinase and cell cycle checkpoint in this preclinical stud…